Tracy Furey

Tracy Furey is a prominent figure in the pharmaceutical industry, currently serving as the Global Head of Novartis Oncology Communications & Engagement and Head of Americas Communications & Engagement at Novartis. In her role, she is responsible for overseeing communication strategies and enhancing the reputation of Novartis within the oncology sector, focusing on health equity and community engagement initiatives.

Furey has been instrumental in initiatives like the Beacon of Hope, a ten-year collaboration aimed at addressing systemic racism and health disparities in the U.S. healthcare system. This initiative includes a significant financial commitment of $33.7 million to support educational programs and increase minority participation in clinical trials, which are critical for improving health outcomes among underserved populations.1

Before her current position at Novartis, Furey held various leadership roles in corporate communications across different organizations, including Vice President positions at companies such as General Motors and Equinix. Her extensive experience in corporate communications has equipped her with a robust skill set in strategy development and reputation management.2

Furey is also recognized for her advocacy within Novartis, particularly as an Executive Sponsor for PRIDE, an employee resource group that promotes diversity and inclusion within the company.1